0001401914-23-000032.txt : 20230621
0001401914-23-000032.hdr.sgml : 20230621
20230621214317
ACCESSION NUMBER: 0001401914-23-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230621
FILED AS OF DATE: 20230621
DATE AS OF CHANGE: 20230621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ononye-Onyia Sophia Nnenna
CENTRAL INDEX KEY: 0001857183
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36395
FILM NUMBER: 231031400
MAIL ADDRESS:
STREET 1: 1270 AVE OF THE AMERICAS
STREET 2: 7TH FL - 1026
CITY: NEW YORK
STATE: NY
ZIP: 10020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dare Bioscience, Inc.
CENTRAL INDEX KEY: 0001401914
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 204139823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3655 NOBEL DRIVE
STREET 2: SUITE 260
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-926-7655
MAIL ADDRESS:
STREET 1: 3655 NOBEL DRIVE
STREET 2: SUITE 260
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
FORMER COMPANY:
FORMER CONFORMED NAME: Cerulean Pharma Inc.
DATE OF NAME CHANGE: 20090714
FORMER COMPANY:
FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070604
4
1
wk-form4_1687398187.xml
FORM 4
X0407
4
2023-06-21
0
0001401914
Dare Bioscience, Inc.
DARE
0001857183
Ononye-Onyia Sophia Nnenna
3544 NOBEL DRIVE
SUITE 260
SAN DIEGO
CA
92122
1
0
0
0
0
Stock Option (right to buy)
0.96
2023-06-21
4
A
0
40000
0
A
2033-06-21
Common stock
40000
40000
D
This option will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the issuer's first annual meeting of stockholders occurring after the grant date, subject to the director's continued service as a director, and will become exercisable in full upon a change in control of the issuer.
/s/Lisa Walters-Hoffert, Attorney-in-fact
2023-06-21